CTT Pharmaceutical Holdings Company Description

CTT Pharmaceutical Holdings, Inc. engages in the development of oral drug delivery systems for pain management and treatment.

It focuses on fast dissolving drug delivery systems. The company’s technology platform includes the development of advanced oral delivery thin wafers infused with both natural and/or synthetic cannabis extracts to deliver treatment as an alternate to smoking and ingestion.

Its principal asset is a patented orally administered wafer, an orally administrable wafer comprising at least one physiologically acceptable film forming agent.

The company was formerly known as Mindesta Inc. and changed its name to CTT Pharmaceutical Holdings, Inc. in July 2015.

The company is based in Ottawa, Canada.

CTT Pharmaceutical Holdings, Inc.

Country	United States
Industry	Drug Manufacturers - Specialty & Generic
Sector	Healthcare
CEO	Ryan Khouri

Contact Details

Address: 429 Kent Street unit 112 Ottawa, Delaware K2P 2B4 Canada
Phone	613-241-9959
Website	cttpharmaceuticals.com

Stock Details

Ticker Symbol	CTTH
Exchange	OTCMKTS
Stock Type	Common Stock
Fiscal Year	January - December
Reporting Currency	USD
ISIN Number	US12651E1064
SIC Code	2834

Key Executives

Name	Position
Ryan Khouri	Chief Executive Officer and Director
Marc Lakmaaker	Special Advisor and Senior Vice President of Commercial Development